He will also lead Aragen’s IDD business and will be responsible for formulation and execution of the IDD strategy with P&L responsibility. Ramarao comes with over 25 years of multidisciplinary ...

After the official launch of their party National Citizen Party, the young leaders who were at the forefront of the July uprising are now focusing on finalising the party's organogram, slogan ...

Aragen Life Sciences announced on Jan. 13 that it has secured a $100 million investment from Quadria Capital, a private equity fund focused on Asian health-care companies. Aragen, based in ...

Contract research, manufacturing and development firm Aragen has hauled in a $100 million investment from private equity group Quadria Capital. India-based Aragen plans to use the funds to expand ...

Contract research, development and manufacturing organisation (CRDMO) Aragen Life Science has secured a $100 million investment from Asia healthcare-focused private equity fund Quadria Capital.

Aragen Life Sciences, a global Contract Research, Development, and Manufacturing Organisation (CRDMO), has secured $100 million investment from Quadria Capital, an Asia-focussed healthcare private ...

Contract research, development and manufacturing organisation Aragen on Monday said it has secured USD 100 million investment from private equity fund Quadria Capital. The investment will result in ...

Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The investment will support Aragen’s strategic ...

Hyderabad, Jan 13 (UNI) Hyderabad-based Aragen, a globally renowned Contract Research, Development, and Manufacturing Organization (CRDMO), on Monday announced that it has secured a $100 Mn investment ...

Aragen, a globally renowned contract research, development and manufacturing organization (CRDMO), announced that it has secured a $100 million investment from Quadria Capital, an Asia ...

Healthcare-focused private equity firm Quadria Capital is investing $100 million (about Rs 860 crore) in Hyderabad-based contract drug development and manufacturing company Aragen Life Sciences Ltd.